News Sideindhold2026PhD defence on June 29, 2026PhD defence on June 9, 2026PhD defence on May 18, 20262025PhD defence on December 17, 2025PhD defence on November 24, 2025PhD defence on September 29, 2025PhD defence on September 22, 2025EIC Transition grant (EU)PhD defence on March 6, 2025PhD defence on February 20, 20252024PhD defence on December 19, 2024PhD defence on October 9, 2024PhD defence on September 20, 2024PhD defence on June 24, 2024Join this Nature Communication webinar on recent developments in adoptive cell therapies for cancer treatment is discussed. Different therapeutic approaches (tumor-infiltrating lymphocytes-therapy, chimeric antigen receptor (CAR)-T, CAR-NK, CAR-macrophages) are presented and discussed by a panel of experts inclucing Inge Marie Svane. Find the webinar herePhD defence on April 24, 2024.Inge Marie Svane awarded the Hubertus Wald Award 2023. Read more here2023Successful CTA submission to the Danish Medicines Agency of the first non-viral CRISPR-modified TIL therapy in metastatic melanoma. Click here for more information (in Danish) Tumour-infiltrating lymphocyte cancer therapy nears FDA finish line. CCIT is working to make this life-saving treatment affordable and accessible. Go here for free access at Nature Reviews Drug Discovery (only for a limited time)Marco Donia received an Ascending Investigator grant from Novo Nordisk Fonden. You can read more about Marco and the grant on the Novo Nordisk Fonden website.PhD defence on June 19, 2023PhD defence on June 15, 2023PhD defence on April 12, 2023Inge Marie Svane was awarded the Danish Oncology Prize 2023. Read more herePhD defence on March 23, 2023PhD defence on March 15, 2023Arianna Draghi received a grant from the NEYE Fonden. You can see more about the grant on NEYE Fonden's web page (in Danish).PhD defence on Januar 17, 20232022Results of the M14TIL trial have been published in the New England Journal of Medicine. Go here to read the press release ImmunoOncology talk by Inge Marie Svane on Sanofi.se. Titel: Tumor-Infiltrating Lymphocyte Based Adoptive Cellular TherapyMEDtalk by Gitte Holmen Olofsson on Best Practice Nordic. Titel: Can High-Intensity Aerobic exercise give patients with cancer better survival by stimulating the immune system?Results of the M14TIL trial have been presented: the world's first phase 3 trial looking into the effects of T cell therapy in solid tumors. Go here to read the press release.PhD defence on August 31, 2022PhD defence on August 29, 2022CCIT-DK and NKI based phase III T-cell therapy trial finalized with positive results. Go here to read more about the trialCCIT-DK is hosting a meeting on Biomarkers in Cancer Immunotherapy. You can read more and see the program here.PhD defence on May 9, 2022Marlies Peeters talks about "Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells". See the video on Jove.com. PhD defence on March 30, 2022PhD defence on March 23, 2022PhD defence on March 21, 2022PhD defence on March 18, 2022Marlies Peeters received the Young Talented Cancer Researcher grant from the Danish Cancer Society. You can see more about the grant on the Danish Cancer Society's web page (in Danish). 2021Acir article about Cathrine Lund Lonrenzen's work. See article on the Acir website.PhD defence on December 2, 2021CCIT-DK receives praise in evaluation from the Danish Cancer Society. See article on the Danish Cancer Society website. The article is in Danish.MEDtalk by Rikke Bødker Holmstrøm on Best Practice Nordic. Titel: Dansk nationalt real-life studie af adjuverende immunterapi til patienter med malignt melanom bekræfter positive resultater. The talk is in Danish.MEDtalk by Rikke Bødker Holmstrøm on Best Practice Nordic. Titel: IL-6 receptor hæmmer dæmper bivirkninger ved immun checkpoint hæmmer behandling. The talk is in Danish.PhD defence on September 7, 2021PhD defence on September 1, 2021Inge Marie Svane honoured with the Marie and August Krogh Prize for her pionering efforts against cancer. You will find an article with more information here.Morten Holmström and Anders Kverneland have been awarded this year's competitive Translational Excellence Programme Fellowships. The new BRIDGE fellows will conduct studies into pancreas cancer and the side effects to immune therapy at the molecular level. You can read more about Morten Holmström here and about Anders Kverneland here.CCIT-DK will be hosting a seminar about the side effects of immune therapy on September 27. You can read more about the seminar here (in Danish). 2020PhD defence on September 2, 2020Article in Oncotarget "Adoptive cell therapy in combination with checkpoint inhibitors". See article hereCCIT-DK receives new grant from the Danish Health Authotity. See article (in Danish) here.CCIT-DK will be hosting a seminar about the side effects of immune therapy on April 27. The seminar was cancelled due to Covid-19.2019Marco Donia and Daniel Hargbøl Madsen awarded the Lundbeck Foundation Fellowship. The fellowships are awarded to particularly promising young scientists who are qualified to establish or develop a research team. See LinkedIn article (in Danish) here. The Lundbeck Foundation also produced a small video about each fellow (in Danish). You can watch them here: Marco Donia and Daniel H. MadsenPhD defence on November 20MEDtalk on Uveal Melanoma from ESMO by Kalijn Bol from bestprac.dk - the talk is in EnglishPhD defence on October 1stIMMUNONET - New leads in Cancer ImmunotherapyPhD defence on September 18PhD defence on September 17Immunitrack together with CCIT receive Eurostars funding for a novel prediction tool to enhance cancer vaccine performance and help monitor patients’ immune responses during novel drug developmentMarco Donia received Fabrikant Ulrik Brinch og hustru Marie Brinchs legat on March 8, 2019. The grant is awarded to younger scientist for excellent scientific work. Large grant for Inge Marie Svane from the Danish Health Authority. See article on the Region H web-site here (in Danish).PhD defence on March 12018Marco Donia received a Sapere Aude grant from The Independant Research Fund Denmark. Read more about Marco and his project on the Independant Research Fund Denmark web-site.IMMUNONET Workshop - Public-Private partnership in Immuno-OncologyPhD defence on December 11Article about "New possibilities in PD-1 cancer treatment" (in Danish) by Morten HansenNew paper from CCIT on Long-term responses in Non-Small-Cell Lung Cancer Mads Hald Andersen and Inge Marie Svane gave talks at Herlev Hospital for the first in a series of information meetings called Vores Viden. See short video (in Danish) here.IMMUNONET Workshop – Public-Private Partnership in Immuno-Oncology on November 5Inge Marie Svane, talk at Danish Cancer Research Days (in Danish) on August 30New Clinical Academic Group in Cancer Immunotherapy - CAGciIMMUNONET inaugural conference on June 13PhD defence on April 4PhD defence on February 26Marco Donia, talk on Immune Therapy at Ballerup Bibliotek, February 7 at 19.00 (in Danish). You can read more here (in Danish).Visit from Japan on February 5 - 82017PhD defence on December 18RXI pharmaceuticals and The Center for Cancer Immune Therapy at Herlev Hospital announce research collaboration PhD defence on October 2PhD defence on September 19PhD defence on September 4MEDtalk from ESMO by Magnus Pedersen on bestprac.dk - the talk is in DanishMEDtalk from ESMO by Julie Westerlin Kjeldsen on bestprac.dk - the talk is in DanishPhD defence on March 30MedwireNews also writes about the study. Read the piece here.ASCO Post writes about important new study from CCIT. Read the piece in ASCO post here Inge Marie Svane receives The Danish Cancer Society's Honorary Award - article in Danish, The Award was Presented by HRH The Crown Princess. The event was also covered (in Danish) by TV2 LorryMarco Donia receives The Danish Cancer Society Junior Research Award - article in Danish.2016Interview with Inge Marie Svane on immune therapy on cancer.dkInge Marie Svane has received funding from The Danish Cancer SocietyWebinar on immune therapy held by Inge Marie Svane on bestprac.dk - the talks are in DanishPer Kongsted received funding from the local branch of The Danish Cancer Society in Nyborg Daniel Hargbøl Madsen has received funding from The Danish Cancer Society2015Nicolai Grønne Jørgensen has received funding from The Danish Cancer Society.Funding from Region Hovedstadens Forskningsfond and The Danish Cancer SocietyPhD defence on June 29Funding from The Danish Cancer SocietyCancer vaccine to be developed by new biotech company